Ferreira Juan Camilo Arjona Myovant Sciences Ltd. (MYOV) insider trading activity

Ferreira Juan Camilo Arjona is Chief Medical Officer of Myovant Sciences Ltd.. Currently has a direct ownership of 0 shares of MYOV, which is worth approximately $0. The most recent transaction as insider was on May 28, 2021, when has been sold 3,083 shares (Common Shares) at a price of $24.0 per share, resulting in proceeds of $73,992. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Ferreira Juan Camilo Arjona Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 28 2021	SELL Open market or private sale	$73,992 $24.0 p/Share	3,083 Reduced 1.72%	176,084 Common Shares
May 28 2021	BUY Exercise of conversion of derivative security	$10,114 $7.78 p/Share	1,300 Added 0.72%	179,167 Common Shares
May 26 2021	SELL Open market or private sale	$307,721 $24.23 p/Share	12,700 Reduced 6.66%	177,867 Common Shares
May 26 2021	BUY Exercise of conversion of derivative security	$98,806 $7.78 p/Share	12,700 Added 6.25%	190,567 Common Shares
Apr 15 2021	BUY Grant, award, or other acquisition	-	51,446 Added 22.43%	177,867 Common Shares
Apr 06 2021	SELL Open market or private sale	$151,164 $18.63 p/Share	8,114 Reduced 6.03%	126,421 Common Shares
Mar 19 2021	SELL Open market or private sale	$169,190 $24.17 p/Share	7,000 Reduced 4.95%	134,535 Common Shares
Mar 19 2021	BUY Exercise of conversion of derivative security	$54,460 $7.78 p/Share	7,000 Added 4.71%	141,535 Common Shares
Mar 01 2021	SELL Open market or private sale	$34,118 $22.55 p/Share	1,513 Reduced 1.11%	134,535 Common Shares
Dec 18 2020	SELL Open market or private sale	$52,000 $26.0 p/Share	2,000 Reduced 1.45%	136,048 Common Shares
Dec 18 2020	BUY Exercise of conversion of derivative security	$15,560 $7.78 p/Share	2,000 Added 1.43%	138,048 Common Shares
Dec 15 2020	SELL Open market or private sale	$167,440 $23.92 p/Share	7,000 Reduced 4.89%	136,048 Common Shares
Dec 15 2020	BUY Exercise of conversion of derivative security	$54,460 $7.78 p/Share	7,000 Added 4.67%	143,048 Common Shares
Dec 10 2020	SELL Open market or private sale	$260,400 $26.04 p/Share	10,000 Reduced 6.85%	136,048 Common Shares
Dec 10 2020	BUY Exercise of conversion of derivative security	$77,800 $7.78 p/Share	10,000 Added 6.41%	146,048 Common Shares
Nov 30 2020	SELL Open market or private sale	$46,780 $23.65 p/Share	1,978 Reduced 1.43%	136,048 Common Shares
Nov 17 2020	SELL Open market or private sale	$140,000 $20.0 p/Share	7,000 Reduced 4.83%	138,026 Common Shares
Nov 17 2020	BUY Exercise of conversion of derivative security	$54,460 $7.78 p/Share	7,000 Added 4.6%	145,026 Common Shares
Nov 13 2020	SELL Open market or private sale	$140,000 $20.0 p/Share	7,000 Reduced 4.83%	138,026 Common Shares
Nov 13 2020	BUY Exercise of conversion of derivative security	$54,460 $7.78 p/Share	7,000 Added 4.6%	145,026 Common Shares

Also insider at

OGN

Organon & Co. Healthcare

Head of R&D & CMO

FJC